Lansley calls for “cultural shift in the NHS”
June 9, 2010NHS, government, king's fund
In his first speech as health secretary Andrew Lansley has called for a “cultural shift in the NHS”, moving away …
Tim Wragg to head up Millward Brown in Europe
June 9, 2010Medical Communications Millward Brown, appointment, medical communications
Research company Millward Brown has appointed Tim Wragg to the newly-created position of chief executive, Europe. In his new position …
Dr Laurent Audoly joins Pieris
June 9, 2010Research and Development Pieris, appointment, research and development
French biotech company Pieris has appointed Dr Laurent Audoly as chief scientific officer. Dr Audoly was most recently biologics research …
Talking Point: Crisis Management
June 9, 2010Medical Communications Red Door, Talking Point
It is surprising to me how many companies and people in business are under-prepared and under-rehearsed for a crisis. On …
EMA sees fewer quality defects in ’09 inspections
June 9, 2010Manufacturing and Production API, EMA, manufacturing, manufacturing compliance
The European Medicines Agency carried out 175 inspections of manufacturing facilities in 2009, a little lower than its target, according …
Eurocom expands international network
June 9, 2010Medical Communications Eurocom, PBK
Eurocom Healthcare Communications has expanded its international communications network, adding leading Austrian agency PBK Ideennrerich to the fold. Eurocom said …
Merck Serono resubmits oral MS therapy to FDA
June 8, 2010Research and Development Cladribine, MS, Merck KGaA
Merck Serono has re-submitted its oral multiple sclerosis therapy cladribine to US regulators. Merck Serono, a Swiss division of Merck …
Sanofi to develop monoclonal antibody jabs
June 8, 2010Research and Development Sanofi Pasteur, Vivalis, vaccines
Sanofi-Aventis is to develop a range of monoclonal antibody for use against infectious diseases. The French pharma company’s vaccines arm …
EU regulators to assess potential lupus breakthrough drug
June 8, 2010Sales and Marketing Benlysta, Human Genome Sciences, Lupus
GlaxoSmithKline and Human Genome Sciences have submitted a marketing application to the European Medicines Agency for their new lupus drug. …
CME Spotlight: Power to the people
June 8, 2010Medical Communications, Sales and Marketing CME Spotlight, transparency
The UK general election is now over and as we stayed up to watch the count, or woke on the …
EMA under fire for blocking data access
June 8, 2010Research and Development, Sales and Marketing Acomplia, Alli, EMA, Xenical, data
The European ombudsman has called for the European Medicines Agency to grant access to clinical study reports and trial protocols …
Digital Pharma: Novo Nordisk’s online ethics tools
June 8, 2010Medical Communications, Sales and Marketing Novo Nordisk, compliance, ethics
Two new e-learning tools have been launched to help shed some light on ethical grey areas and give individuals a …
Idis appoints Richard Greatorex
June 8, 2010Research and Development, Sales and Marketing IDIS, appointment, research and development, sales and marketing
Richard Greatorex has joined specialist medicines supplies company Idis as international marketing manager for its global headquarters in the UK. …
Manufacturing news in brief
June 8, 2010Manufacturing and Production AHP Manufacturing, Caraco Pharmaceutical, Hospira, KV Pharmaceutical, Pharmalucence
The pharmaceutical manufacturing sector had another week of mixed fortunes, with yet more recalls being announced and a former Wyeth …
Chiltern Achieves Supplementary Accreditation from the Medicines & Healthcare Products Regulatory Agency
June 7, 2010Research and Development
Dr Brian Sanderson, Medical Director, Chiltern Early Phase, explains, “In November 2007, the MHRA launched a voluntary accreditation scheme for …
Pfizer launches UK pharmacy service
June 7, 2010NHS, NHS Constitution, NHS Health Check, Pfizer
Pfizer has launched a new pharmacy-based service that will enable Primary Care Trusts in England to provide the NHS Health …
AZ submits Nexium-aspirin combination for EU approval
June 7, 2010Sales and Marketing AstraZeneca, Nexium, aspirin
AstraZeneca is seeking European approval for a new version of its anti-ulcer blockbuster Nexium that combines the pill with aspirin. …
Avastin promising in ovarian cancer
June 7, 2010Research and Development ASCO, avastin
Roche’s Avastin took a step closer to winning an additional indication after phase III trial data showed the blockbuster cancer …
Pfizer recalls Indian-made intravenous drugs
June 7, 2010Manufacturing and Production Claris Lifesciences, Pfizer, manufacturing compliance, recalls
Pfizer is recalling two intravenous antibiotics and an anti-nausea medication after particulate matter was found to be floating in them, leading …
Teva will invest $56m in Canadian plant
June 7, 2010Manufacturing and Production Canada, Teva, production
Israeli generic drugmaker Teva Pharmaceutical Industries is planning to spend $54 million to expand a Canadian production plant for solid …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
